Kawagoe, Japan

Sakthikumar Dasappan Nair

This inventor holds 1 USPTO granted patent. Top assignee: Toyo University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sakthikumar Dasappan Nair. Retrieved from https://idiyas.com/inventor/sakthikumar-dasappan-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Drug Delivery: The Work of Sakthikumar Dasappan Nair

Introduction

Sakthikumar Dasappan Nair is an innovative inventor based in Kawagoe, Japan. He has made significant contributions to the field of drug delivery systems, particularly in developing compositions that can effectively penetrate the blood-brain barrier while maintaining low cytotoxicity.

Latest Patents

Nair holds a patent for a composition titled "RGD and transferrin nanoparticle composition." This invention provides a novel approach to drug delivery by utilizing nanoparticles that are bound to substances with specificity to tumor cells. The composition includes a peptide with an amino acid sequence of arginine-glycine-aspartic acid and an iron-binding protein, enhancing its effectiveness in targeting tumor cells.

Career Highlights

Nair is affiliated with Toyo University, where he continues to advance his research in nanoparticle technology and drug delivery systems. His work is pivotal in addressing challenges associated with delivering therapeutic agents to the brain.

Collaborations

Nair collaborates with esteemed colleagues, including Toru Maekawa and Sheikh Mohamed Mohamed, to further enhance the impact of his research in the field.

Conclusion

Sakthikumar Dasappan Nair's innovative work in drug delivery systems exemplifies the potential of nanoparticle technology in medical applications. His contributions are paving the way for more effective treatments for patients with challenging conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…